Filing Details
- Accession Number:
- 0001104659-22-085790
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-03 21:48:50
- Reporting Period:
- 2020-08-01
- Accepted Time:
- 2022-08-03 21:48:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Plc | NBRV | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1383292 | Jr A Charles Rowland | 414 Commerce Drive Suite 120 Fort Washington PA 19034 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2022-08-01 | 8,496 | $0.18 | 15,277 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
